Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017
- PMID: 33017008
- PMCID: PMC8728029
- DOI: 10.1093/ehjqcco/qcaa076
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017
Abstract
Aims: The aim of this study was to estimate the burden and risk factors for ischaemic heart disease (IHD) in 195 countries and territories from 1990 to 2017.
Methods and results: Data from the Global Burden of Disease Study 2017 were used. Prevalence, incidence, deaths, years lived with disability (YLDs), and years of life lost (YLLs) were metrics used to measure IHD burden. Population attributable fraction was used to estimate the proportion of IHD deaths attributable to potentially modifiable risk factors. Globally, in 2017, 126.5 million [95% uncertainty interval (UI) 118.6 to 134.7] people lived with IHD and 10.6 million (95% UI 9.6 to 11.8) new IHD cases occurred, resulting in 8.9 million (95% UI 8.8 to 9.1) deaths, 5.3 million (95% UI 3.7 to 7.2) YLDs, and 165.0 million (95% UI 162.2 to 168.6) YLLs. Between 1990 and 2017, despite the decrease in age-standardized rates, the global numbers of these burden metrics of IHD have significantly increased. The burden of IHD in 2017 and its temporal trends from 1990 to 2017 varied widely by geographic location. Among all potentially modifiable risk factors, age-standardized IHD deaths worldwide were primarily attributable to dietary risks, high systolic blood pressure, high LDL cholesterol, high fasting plasma glucose, tobacco use, and high body mass index in 2017.
Conclusion: Our results suggested that IHD remains a major public health challenge worldwide. More effective and targeted strategies aimed at implementing cost-effective interventions and addressing modifiable risk factors are urgently needed, particularly in geographies with high or increasing burden.
Keywords: Epidemiology; Global heath; Ischaemic heart disease; Risk factor.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures




Similar articles
-
Burden of Ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study.BMC Cardiovasc Disord. 2018 Feb 2;18(1):18. doi: 10.1186/s12872-018-0761-0. BMC Cardiovasc Disord. 2018. PMID: 29390974 Free PMC article.
-
Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021.Diabetes Obes Metab. 2025 May;27(5):2561-2572. doi: 10.1111/dom.16256. Epub 2025 Feb 18. Diabetes Obes Metab. 2025. PMID: 39963796 Free PMC article.
-
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors in youth from 1990 to 2019: a Global Burden of Disease study.Public Health. 2024 Nov;236:43-51. doi: 10.1016/j.puhe.2024.07.011. Epub 2024 Aug 18. Public Health. 2024. PMID: 39159577
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
Cited by
-
Changes in ultra-processed food consumption during the first Italian lockdown following the COVID-19 pandemic and major correlates: results from two population-based cohorts.Public Health Nutr. 2021 Aug;24(12):3905-3915. doi: 10.1017/S1368980021000999. Epub 2021 Mar 5. Public Health Nutr. 2021. PMID: 33663640 Free PMC article.
-
A Synergistic Effect between Plasma Dickkopf-1 and Obstructive Coronary Artery Disease on the Prediction of Major Adverse Cardiac Events in Patients with Angina: An Observational Study.Biomolecules. 2022 Oct 2;12(10):1408. doi: 10.3390/biom12101408. Biomolecules. 2022. PMID: 36291617 Free PMC article.
-
Prevalence and Mortality of Hypochloremia Among Patients Suffering From Coronary Artery Disease and Congestive Heart Failure: An Analysis of Patients in CIN-I and MIMIC-III Databases.Front Med (Lausanne). 2021 Dec 21;8:769646. doi: 10.3389/fmed.2021.769646. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34993210 Free PMC article.
-
The mortality trends analysis of ischemic heart disease attributed to (PM) 2.5 exposure in China from 1990 to 2019 in APC model.Am J Transl Res. 2023 Aug 15;15(8):5495-5507. eCollection 2023. Am J Transl Res. 2023. PMID: 37692945 Free PMC article.
-
Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.BMC Cardiovasc Disord. 2021 Dec 27;21(1):613. doi: 10.1186/s12872-021-02431-6. BMC Cardiovasc Disord. 2021. PMID: 34961476 Free PMC article.
References
-
- Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al. ; On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 update: a report from the American Heart Association. Circulation 2020;141:e139–e596. - PubMed
-
- Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol 2014;171:368–376. - PubMed